What is Nurix Therapeutics, Inc.'s accrued clinical?

Nurix Therapeutics, Inc. (NRIX) reported accrued clinical of $10.77M in Q4 2025.

How has Nurix Therapeutics, Inc.'s accrued clinical changed year-over-year?

Nurix Therapeutics, Inc.'s accrued clinical increased by 60.6% year-over-year, from $6.7M to $10.77M.

What does accrued clinical mean?

This represents the short-term financial obligations related to ongoing clinical trial activities, including patient recruitment, site monitoring, and data management services. It reflects the near-term cash requirements necessary to sustain the company's clinical development programs.

Nurix Therapeutics, Inc. NRIX Accrued clinical

Accrued clinical at other companies

BillionToOne, Inc. BLLN

$224K—

CelcuityCELC

$8.77M—

Ionis PharmaceuticalsIONS

$53.33M-21.1%

Schering-PloughSGP

$2.18M+70.2%

Nuvalent, Inc.NUVL

$58.92M+20.6%

CelcuityCELC

-$8.06M-636%

Other financials

Income statement

See full

Revenue$6.3M-66.1%

Operating income-$92.5M-47.1%

Net income-$87.2M-54.7%

EPS (diluted)-$0.79-17.9%

Balance sheet

See full

Cash & equivalents$72.2M-6.1%

Total debt$58.7M+120%

Total equity$480.9M0.0%

Total assets$636.1M+3.4%

Cash flow

See full

Operating cash flow-$71.9M-17.7%

CapEx$1.0M-70.0%

Free cash flow-$73.0M-13.0%

Valuation

See full

Market cap$1.95B+40.1%

Enterprise value$1.94B+45.1%

P/S27.2×+2.5×

Profitability

See full

Operating margin-439.3%+35.3pp

Net margin-411.4%+52.7pp

FCF margin-378.7%+24.1pp

Returns & leverage

See full

Return on equity-61.4%-2.5pp

Debt / equity0.1×+0.1×

Current ratio6×-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept nrix:AccruedClinicalCurrent.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s accrued clinical.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s accrued clinical?: Nurix Therapeutics, Inc. (NRIX) reported accrued clinical of $10.77M in Q4 2025.
How has Nurix Therapeutics, Inc.'s accrued clinical changed year-over-year?: Nurix Therapeutics, Inc.'s accrued clinical increased by 60.6% year-over-year, from $6.7M to $10.77M.
What does accrued clinical mean?: This represents the short-term financial obligations related to ongoing clinical trial activities, including patient recruitment, site monitoring, and data management services. It reflects the near-term cash requirements necessary to sustain the company's clinical development programs.